SIGA Technologies, Inc. Profile Avatar - Palmy Investing

SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox dise…

Drug Manufacturers - Specialty & Generic
US, New York [HQ]

Resulting Ratios

15 Records · Starting from 2009
Loading...
End of SIGA's Analysis
CIK: 1010086 CUSIP: 826917106 ISIN: US8269171067 LEI: - UEI: -
Secondary Listings
SIGA has no secondary listings inside our databases.